21st Century Fund

The goal of the 21st Century Fund is to support the resolution of next-stage capital formation issues by co-investing with institutional investors in order to further build innovative, high-impact, high-growth companies. As the 21 Fund's manager, Elevate works with early revenue-generating companies to solve product demonstration and market penetration issues in order to accelerate company growth, milestone achievement, and job creation. Technical and business analysis is conducted by Elevate Ventures staff using a structured internal venture validation process. If necessary, Elevate Ventures' Entrepreneurs-in-Residence work with applicants to ensure that the technical and business plans are structured to make this review efficient and to provide useful feedback to the company. The 21st Century Fund is sensitive to the acute challenges facing early-stage life science companies, especially in therapeutic verticals. They continue to be open to such opportunities and strive to meet associated capital-intensive product development needs alongside institutional or strategic investors. The 21 Fund's maximum investment size is $2 million per company. Certain criteria for investment includes: for-profit entity headquartered in Indiana, addressable market size over $1 billion, disruptive business models, coachable management team, and achievable growth and exit strategies.